Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 24 2024
0mins
Source: PRnewswire
New Appointments: Ascentage Pharma has appointed Ms. Marina S. Bozilenko and Dr. Debra Yu as independent non-executive directors, effective November 25, 2024, to enhance its strategic management and innovation efforts in the biopharmaceutical sector.
Company Overview: Ascentage Pharma is a global biopharmaceutical company focused on developing therapies for malignancies, with a robust pipeline of drug candidates and significant clinical trial activity across multiple regions, including China and the US.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
